Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A T Chiu

Showing results (51-60 of 83) with videos related to

Pageof 9
Sort By:
Biochemical and Biophysical Research Communications|October 31, 1989
Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivoT M Reilly, D S Taylor, W F Herblin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2)P C Wong, S D Hart, A M Zaspel, et al.
Journal of Medicinal Chemistry|May 1, 1990
Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensivesD J Carini, J V Duncia, A L Johnson, et al.
American Journal of Hypertension|December 1, 1992
Rationale for the chemical development of angiotensin II receptor antagonistsR R Wexler, D J Carini, J V Duncia, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agentP C Wong, W A Price, A T Chiu, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1990
Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: XP C Wong, W A Price, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307)P C Wong, A T Chiu, W A Price, et al.
Biochemical and Biophysical Research Communications|September 30, 1991
Inhibition of the thrombin-platelet reactions by DuP 714A T Chiu, S A Mousa, L J Pease, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1990
Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753P C Wong, W A Price, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agentP C Wong, W A Price, A T Chiu, et al.
Pageof 9

Showing results (51-60 of 83) with videos related to

Sort By:
Pageof 9
Biochemical and Biophysical Research Communications|October 31, 1989
Monoclonal antibodies directed against basic fibroblast growth factor which inhibit its biological activity in vitro and in vivoT M Reilly, D S Taylor, W F Herblin, et al.
The Journal of Pharmacology and Experimental Therapeutics|November 1, 1990
Functional studies of nonpeptide angiotensin II receptor subtype-specific ligands: DuP 753 (AII-1) and PD123177 (AII-2)P C Wong, S D Hart, A M Zaspel, et al.
Journal of Medicinal Chemistry|May 1, 1990
Nonpeptide angiotensin II receptor antagonists: N-[(benzyloxy)benzyl]imidazoles and related compounds as potent antihypertensivesD J Carini, J V Duncia, A L Johnson, et al.
American Journal of Hypertension|December 1, 1992
Rationale for the chemical development of angiotensin II receptor antagonistsR R Wexler, D J Carini, J V Duncia, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Nonpeptide angiotensin II receptor antagonists. VIII. Characterization of functional antagonism displayed by DuP 753, an orally active antihypertensive agentP C Wong, W A Price, A T Chiu, et al.
Hypertension (Dallas, Tex. : 1979)|May 1, 1990
Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: XP C Wong, W A Price, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 1, 1988
Nonpeptide angiotensin II receptor antagonists. I. Pharmacological characterization of 2-n-butyl-4-chloro-1-(2-chlorobenzyl)imidazole-5-acetic acid, sodium salt (S-8307)P C Wong, A T Chiu, W A Price, et al.
Biochemical and Biophysical Research Communications|September 30, 1991
Inhibition of the thrombin-platelet reactions by DuP 714A T Chiu, S A Mousa, L J Pease, et al.
Hypertension (Dallas, Tex. : 1979)|June 1, 1990
Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753P C Wong, W A Price, A T Chiu, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1990
Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agentP C Wong, W A Price, A T Chiu, et al.
Pageof 9